-
When high-risk HIV/AIDS patients are about to be discharged from Presbyterian Hospital in New York, physicians will call an outside organization called AIDS Service Center of New York for help with the transition in care.
-
Discharge planners and others might find the rules confusing with regards to consolidated billing (CB) under the Balanced Budget Act (BBA) of 1997. This may be particularly true when patients are discharged to skilled nursing facilities (SNFs) and home health services.
-
-
In some ways, the direction health care is heading could be seen as a back-to-the-future scenario.
-
As the economy worsens and the rolls of the unemployed and uninsured increase, hospitals can expect some hard times, as well, an expert says.
-
Whether oral vitamin K reduces the risk of bleeding related to excessive anticoagulation from warfarin remains unclear.
-
In an international, multi-center trial of azacitidine in patients with either intermediate-2 or high-risk MDS, overall survival was significantly increased when compared to conventional therapy, which at the discretion of the investigator and patient, could have included intense chemotherapy, low-dose cytarabine, or best supportive care.
-
Using a "dose-dense" regimen of paclitaxel and carboplatin in heavily pre-treated, platinum- resistant ovarian cancer patients, a UK oncology group demonstrated that a more protracted treatment schedule (six months) was both tolerable and associated with an impressive overall response rate (60%). The findings provide rationale for a randomized clinical trial to examine this approach for relapsed ovarian cancer, particularly for those who relapse within a year of completing initial platinum-based treatment.
-
Of 688 breast cancers occurring in 652 women 35 years and younger, 15.6% were associated with pregnancy (either during pregnancy or during the subsequent year). Although the tumors occurring in association with pregnancy were larger, there was no significant difference in local recurrence, distant metastases, or overall survival.
-
In patients with advanced- or high-risk but local prostate cancer, the addition of local radiotherapy to endocrine treatment was shown to halve the 10-year prostate cancer-specific mortality and substantially reduce overall mortality in a phase III, randomized, multi-center clinical trial conducted in Northern Europe.
